Hypocomplementaemia has been described in patients with active IgG4‐RD.31, 32 In this study, C3 and/or C4 levels were reduced in 23% of 22 IgG4‐RD patients. This evidence concerns the gene C3 and immunoglobulin G4-related sclerosing disease.